No previous suggestions found.
1
Home
Companies

AbCellera

#5841

Rank

$841.79M

Marketcap

CA Canada

Country

AbCellera
Leadership team

Dr. Carl L.G. Hansen Ph.D. (CEO, Pres & Chairperson)

Mr. Andrew Booth M.B.A. (Chief Financial Officer)

Dr. Veronique Lecault Ph.D. (COO & Director)

Products/ Services
Biotechnology, Medical, Therapeutics
Number of Employees
100 - 500
Headquarters
Vancouver, British Columbia, Canada
Established
2012
Company Registration
SEC CIK number: 0001703057
Net Income
100M - 500M
Revenue
500M - 1B
Traded as
ABCL
Social Media
URL
https://www.abcellera.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
History

AbCellera was founded in 2012 by Carl Hansen and Ryan Cawood. Since then, the company has grown exponentially, with offices in Vancouver, Canada and San Francisco, CA. AbCellera has developed a platform for the discovery of therapeutic antibodies that is used by over 200 partners worldwide.

Mission
Our mission is to revolutionize the discovery of antibody-based drugs by harnessing the power of the human immune system.
Vision
Our vision is to build a more equitable and accessible healthcare industry by driving the development of novel therapies through our innovative technologies.
Key Team

Mr. Tryn T. Stimart Esq., J.D. (Chief Legal Officer, Chief Compliance Officer & Corp. Sec.)

Dr. Ester Falconer Ph.D. (Chief Technology Officer)

Mr. Bo Barnhart Ph.D. (Scientific Director)

Ms. Tiffany Chiu B.Sc., Ph.D. (VP of Communications)

Mr. Murray McCutcheon Ph.D. (VP of Corp. Devel.)

Caitlin Webster CIPD, M.Sc. (Sr. Mang. of People & Culture)

Alexandra Weirich M.Sc. (Mang. of Marketing & Communications)

Recognition and Awards
AbCellera has been awarded numerous awards, such as the Innovator of the Year Award in both 2018 and 2019, and the Governor General's Innovation Award in 2021.
References

https://en.wikipedia.org/wiki/AbCellera

https://in.investing.com/equities/abcellera-biologics

https://finance.yahoo.com/quote/ABCL/profile?p=ABCL

https://www.crunchbase.com/organization/abcellera-biologics

https://sec.report/CIK/0001703057

https://companiesmarketcap.com/

https://www.abcellera.com

AbCellera
Leadership team

Dr. Carl L.G. Hansen Ph.D. (CEO, Pres & Chairperson)

Mr. Andrew Booth M.B.A. (Chief Financial Officer)

Dr. Veronique Lecault Ph.D. (COO & Director)

Products/ Services
Biotechnology, Medical, Therapeutics
Number of Employees
100 - 500
Headquarters
Vancouver, British Columbia, Canada
Established
2012
Company Registration
SEC CIK number: 0001703057
Net Income
100M - 500M
Revenue
500M - 1B
Traded as
ABCL
Social Media
URL
https://www.abcellera.com
About

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

businessabc@ztudium.com

Follow Us
Produced by
In collaboration with
Logo

Copyright 2024 © Businessabc powered by ztudium

Privacy Policy